Month: August 2025

Strong second quarter for Kinepolis cinemas thanks to international blockbusters Regulated information 21 August 2025, 7.00 am CET After a weak start to the year due to a limited blockbuster offering, Kinepolis posted strong second-quarter results, driven by a robust international film lineup and an effective premiumisation strategy. The success of ‘A Minecraft Movie’, ‘Lilo & Stitch’ and ‘Mission Impossible: The Final Reckoning’, among others, boosted visitor numbers by 17.3% in the second quarter compared to the same period last year, resulting in a 2.2% increase in visitors and a 6.2% increase in revenue for the full first half of the year. Revenue per visitor increased again, thanks in part to higher demand for experience and an expansion of the premium movie experience offering. Adjusted EBITDAL rose by as much as 22.6% to €...

Dubai, UAE, Aug. 21, 2025 (GLOBE NEWSWIRE) — Vantage Drilling International Ltd. (“Vantage” or the “Company”) today announced that it will host a conference call at 10:00 AM Eastern Time / 4:00 PM Oslo Time / 6:00 PM Dubai Time on August 28, 2025, to discuss operating results for the second quarter of 2025. Vantage will release earnings before the call on August 28, 2025. Vantage’s earnings release will be posted to the Vantage website at www.vantagedrilling.com.  To access the conference call, click on the Call Link following the instructions below. Click on the Call Link and complete the online registration form. Once the registration is complete you will receive an email confirmation with the call details (dial-in and a unique PIN to join the call). You will have two options...

Oslo, 21 August 2025 – DNO ASA, the Norwegian oil and gas operator, today reported strong second quarter results with revenue up 37 percent to USD 258 million from the prior quarter and operating profit up 206 percent to USD 86 million, even with the contribution from the transformative USD 1.6 billion acquisition of Sval Energi Group AS in Norway recorded only as from 1 June 2025. Net production during the quarter increased 10 percent to 92,600 barrels of oil equivalent per day (boepd), of which 56,100 boepd from the Kurdistan region of Iraq, 33,300 boepd from the North Sea and 3,200 boepd from West Africa. With the addition of the Sval Energi assets, projected second half 2025 North Sea production is 80,000-85,000 boepd. While months-long repairs are pending and security concerns remain following drone strikes on DNO operated fields...

HighlightsThe Hearing division delivered 8% organic revenue growth driven by broad-based market share gains of ReSound Vivia across global markets growing below structural trends. The strong growth led to 12% growth in divisional profit, equaling a divisional profit margin of 36% driven by operating leverage The Enterprise division was – as expected – challenged by market uncertainty due to the global trade environment. The organic revenue growth was -7% due to the market uncertainty and a difficult comparison base, while being supported by strong progress in FalCom. The divisional profit margin ended at 34% as a result of pricing discipline and cost focus, offsetting the direct tariff costs The Gaming division was – as expected – challenged by the tariff environment and weak consumer sentiment. Despite these challenges, Gaming performed...

Growth in the sea has been very good, paving the way for increased volume, with a higher share of superior quality fish, and positive cost development in the second half of the year. As expected, the second quarter was marked by weak price achievement due to a high proportion of downgraded fish, particularly in Central Norway. Operational EBIT for Norway was NOK 696 million in Q2 2025. The harvest volume was 54,500 tonnes, and operational EBIT per kg was NOK 12.8. Group operational EBIT was NOK 524 million in Q2 2025. The harvest volume was 64,500 tonnes, and the EBIT per kg was NOK 8.1. Strong biological performance from Northern Norway with positive cost development during the period. Very good results from Sales and Industry driven by positive contributions from contracts and capabilities in our set-up. SalMar Ocean completed harvest...

MELBOURNE, Australia and INDIANAPOLIS, Aug. 21, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces its financial results for the half-year ended 30 June 2025. All figures are in USD unless stated otherwise. H1 2025 key results1 Group performance2: Reflects strategic investment for long-term value creationRevenue of $390.4 million, up by 63%3 and on track to meet full year guidance4. Group gross profit margin of 53% reflects product mix change to include third-party RLS sales. Illuccix® margin remains stable. Adjusted EBITDA5 of $21.1 million, reflective of increased operating expenditure driven by strategic acquisitions, investment in commercial infrastructure, and research and development (R&D) investment. $81.6 million invested into R&D, a 47% increase...

Product sales from Olverembatinib in the first half of 2025 increased 93% year-over-year to US$30.3 million (RMB217.4 million), primarily attributable to the expansion of NRDL coverage Commenced commercial sales of Lisaftoclax in China, following approval on July 10, 2025 by China’s NMPA for the treatment of adult patients with CLL/SLL who have previously received at least one systemic therapy including BTK inhibitors Registrational Phase III trial for 1L HR MDS (GLORA-4) cleared by FDA and EMA, and first patients enrolled in Europe and China Completed a top-up placement in July 2025, resulting in US$190.1 million in net proceeds Nine registrational clinical trials are in progress, including three cleared by FDA Chinese (Mandarin) language investor webcast at 9:00 pm EDT on August 20, 2025 / 9:00 am HKT on August 21, 2025, and English...